Category Archives: Immunology

Complement

C3 and C4 are measured at the same time since this gives an indication of the complement pathway (classical or alternative) which is being activated and thus the cause of this activation.

C3 alone is often decreased in infectious disease (septicaemia, endocarditis), so not v interesting if isolated, unless concern about immunodeficiency (see below).

C4 alone is characteristically decreased in hereditary angioedema, can also be immune complex diseases particularly vasculitis, and in cryoglobulinaemia and cold agglutinin disease. Immune complex diseases can lead to consumption of both C3 and C4, with low levels.

Measurement of serum complement is useful in the monitoring of specific immune complex diseases eg SLE, post streptococcal disease, subacute bacterial endocarditis. Consumption of one or both components may also be useful prognostically eg nephritis in lupus.

Deficiency

Complement deficiency is a type of immunodeficiency.  Though genetic C3 deficiency is v rare, deficiencies in other components (which are more common, though still very rare) can result in low C3.  CH50 or CH100 are better tests of whole pathway.

Genetic deficiencies in C4 are rarely detected.

Prevention of allergy and autoimmune disease

See also asthma prevention.

Immune system starts development in the first trimester, in the womb. Some parts (eg IFN gamma) are constrained, probably to protect the placenta. Immunoglobulin (particular A) still developing through early years – airway mucosal dendritic cells still expanding up until puberty.

The major driving force behind postnatal immune development in all mammalian species is microflora of the gastrointestinal tract – “healthy” development requires not just the right balance of microflora, but also at a crucial window in time.

The hygiene hypothesis (David Strachan) has now been modified to include “old friends” (Graham Rook, talking about microbes that have co-evolved with humans) and finally the biodiversity hypothesis.

So lifestyle becomes important – time spent outdoors, time spent in contact with natural habitats, having diverse, unprocessed diets. Fresh fruit and vegetables have their own microbiome, for instance. And these things are heavily linked to socioeconomic status, particularly housing and green space. Role of artificial sweeteners, emulsifiers, plasticisers and other waste organic compounds?

Mode of birth/delivery affects neonatal colonisation (elective vs emergency section or vaginal) – although so far maternal-infant microbial seeding studies have failed to demonstrate health benefits.

More than 20 studies of probiotics and prevention of allergy.  No safety concerns.  15 found supplementation during pregnancy and lactation may reduce eczema, but no effect in asthma, food allergy, rhinitis.

Fish oil (omega-3) supplementation during pregnancy may reduce risk of allergic sensitisation to egg.

Cochrane 2013 review of prebiotics concluded “promising results in high risk populations”, WAO find in favour (probiotics too), but others institutions have not!

Other dietary exposures, including maternal allergenic food avoidance, vitamin, mineral, fruit and vegetable intake did not appear to influence risk of allergic or autoimmune disease.

There is limited evidence to suggest that supporting mothers to breastfeed for longer reduces risk of eczema in the first year. Longer exclusive breastfeeding duration reduces risk of type 1 diabetes.

EAACI have recommended hypoallergenic formula (“one with documented preventive effect”) for 4/12  (Grade I, evidence A-B).  2024 Chinese systematic review found low quality evidence for extremely hydrolysed formula (EHF) reducing risk of cow’s milk allergy [relative risk (RR): 0.62]. Moderate quality evidence for partially hydrolysed (PHF) and EHF reducing risk of eczema in children (even after 2 y – RR: 0.71-0.79). Moderate quality evidence that PHF only reduced risk of wheeze at age 0-2 y compared with CMF (RR: 0.50), but cf with breast milk, both PHF and EHF increased the risk (RR: 1.61 and 64).

[PLoS Med metanalysis 2018]

Sun exposure around time of birth protects against allergy/atopy, according to French study – for one change in interquartile range, sun exposure prenatally had adjusted odds ratio of 0.47 for sensitisation at age 8-9yrs, and 0.32 for asthma. Postnatal effects less strong. Maternal vitamin D supplementation seemed to increase the risk. All the children were from Paris – sun exposure was calculated from meterological data around time of birth, not time spent outdoors. Ethnicity was not reported.  The suggestion is that the mechanism is vitamin D mediated. Previous studies have had mixed results.

Skin

Since eczema commonly precedes food allergy, it is assumed that disruption of the epithelial barrier is the first step in sensitisation (even when a baby is not eating any food) – the “dual allergen exposure” hypothesis. Peanut protein levels in household correlate with peanut sensitisation in high risk babies.

A couple of different skin “endotypes” – protein/ceramide expression, staph aureus abundance – that seem to predict food allergy. Filaggrin mutations are the strongest genetic risk factor for eczema, and the associated disruption in keratinocytes allows for allergens and irritants to penetrate the skin and trigger inflammation. Detergents/pollutants can further disrupt the skin barrier. Low humidity/temperature also affects (autumn/winter births more at risk).

S aureus colonisation is more likely with eczema, and is associated with severity and persistence – it is also associated with reduced tolerance to egg/peanut, and higher IgE milk/egg/peanut.

Cochrane review of emollients as preventive strategy found no evidence of benefit and possibly more infection. Frequent bathing and oil based bath additives increased the risk of eczema. STOP-AD study (ceramide based emollient, first 2 months of life) found reduced eczema incidence at 1yr in high risk infants. Other studies are looking at trilipid rather than petrolatum based emollients.

Japanese study of “proactive topical steroids” at 7-13 weeks of age (including non-affected skin) found 25% reduction in egg allergy but also reduced weight/length! Calcineurin inhibitors may get around the issue of steroid side effects, if safety data in infants becomes available (so far, so good). [Review, 2024]

House dust mite allergy

People assume they are allergic to dust – more likely is that they are allergic to dust mites (HDM).  These are microscopic, and tend to reside in fabrics in the home esp bedding, carpets, sofas.  So your house can be spotless but still be full of mites!

There are a number of different house dust mite species – most are Dermatophagoides (“skin eating”…), D. farinae is the American type, D. pteronyssinus is the European one.

HDM allergy is common in atopic individuals, contributing to eczema, rhinoconjunctivitis and asthma. Eczema usually comes first, but sensitisation (usually develops in young children) seems to predict development of asthma persisting into school age!

Although common, it doesn’t tend to cause immediate reactions, the way cat/dog does, probably because mites don’t fly – so exposure only caused when surfaces disturbed or if skin/nose/mouth/eyes in direct contact. But inflammation may be chronic, from brief, low quantity, frequent exposure. So even with avoidance/ reduction measures, it can take months to see the benefit…

There is cross-sensitivity with shellfish allergy but not fish allergy.

In some parts of the world, mouse and cockroach allergies more of an issue.

Lots of different allergens identified.  der p 1 and 2 are major allergens in mite faeces, in kids with eczema various other allergens found in mite bodies also important. Mite faeces are the most important cause of sensitisation. Composition of skin prick solutions seems to vary…

Avoidance/reduction

Allergy UK has an advice leaflet with different measures for reducing levels of HDM in the home.  Evidence however is that this is difficult to do and rarely seems to have any significant clinical effect!  So no point in doing piecemeal, certainly.

Dust mites need high humidity to get water, so high altitude and air conditioning suppresses them.  They also like temperatures over 20deg. They are photophobic so hide deep in fabrics.

Get rid of carpets, curtains, excess cushions/pillow/throws, move soft toys off bed.

Wash bedding at 60, or tumble dry! Soft toys go in the freezer overnight once a month (in a bag, obviously, to avoid collecting smells). Protective covers for mattresses and hypoallergenic bedding materials.

Some vacuum cleaners are better than others (in theory) eg with HEPMA filter.  Allergy UK approves products (but only if company pay, of course). But the mechanical action of cleaning (plus moving furniture, changing beds etc) can whip particles up into the air (as can emptying the contents of the cleaner) so best done when kids are out, and wait 20 minutes before letting them back in…  Cleaning and replacing filters important too esp if bagless design.

Vacuuming alone resulted in a significant reduction in carpet house dust mite allergen concentration and load. Levels approached pretreatment values by 4 weeks posttreatment in the intensive vacuuming group, whereas combination of dry steam cleaning plus vacuuming lasted up to 8 weeks. 

You can also use a steam cleaner on a mattress!

Evidence for air purifiers is mixed.  If placed on carpet, they can actually disturb more allergen than they remove! You need to close doors and windows of course. Unfortunately the best ones tend to be big, expensive and noisy, and price does not mean good quality. Plus you have to remember to replace the filters. The cheapest Which? recommended one (the Electriq EAP500HC) costs over £200.

In PAXAMA study in the NW England (kids with a history of wheeze requiring a visit to hospital), impermeable covers (blinded!) halved risk of having an emergency hospital attendance over the next year. [Murray 2017] Maximum benefit was seen in under 11yrs, mono-sensitized to mite, living in nonsmoking households, and requiring more ICS.  

[JACI 2018]

Immunotherapy

Systematic review found good evidence of benefit for eczema with immunotherapy against house dust mite, with subcut immunotherapy superior to sublingual. [Journal of Allergy & Clinical Immunology. 151(1):147-158, 2023 PMID 36191689]

Evidence for immunotherapy for allergic rhinitis, at least in adults… Treatment effect from 14 weeks, so not rapid…

No evidence for asthma but given as indication… although research into whether HDM immunotherapy might prevent.

NICE approved Acarizax for moderate to severe HDM rhinitis from age 12 in the NHS in England in January 2025. Acarizax is sublingual therapy (derived from D pteronyssinus and D farinae), indicated in adolescents (12-17 years) as well as adults diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific IgE) with persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication.

NICE appraisal also comments that avoidance/reduction of HDM burden in home is almost impossible and if problems persist, it can induce strong feelings of guilt in parents/carers.

Also, many patients would prefer not to be using regular, large doses of steroids, even if effective.

£80 a month on NHS, has not been submitted to Scottish Medicines Consortium so currently not recommended.

International treatment guidelines refer to a treatment period of 3 years for allergy immunotherapy to achieve disease modification. Efficacy data is available for 18 months of treatment with ACARIZAX in adults; no data is available for 3 years of treatment. If no benefit in first year, no indication to continue.

First dose should be observed and the patient monitored for at least 30 minutes.

Place under the tongue, avoid swallowing for 1 minute, avoid food/drink for 5 minutes.

Contraindications are FEV1 <70% of predicted value despite treatment, or severe asthma exacerbation within the last 3 months.

If oral ulceration, postpone treatment.

Eosinophilic oesophagitis has been reported.

Accidental Adrenaline self-injection

eg with Epipen or Emerade.

Causes vasoconstriction with potential for gangrene.

Try:

  • warm water immersion
  • local nitroglycerin paste
  • subcut infiltration with a mixture of 1.5mg of phentolamine, 1mL of 2% lidocaine (at site and along course of digital arteries)

[advised by National Poisons Information Service]

n=365 adrenaline injections to hand, 213 to digit.  No cases with clinically apparent systemic effects, only a few patients had ischemia. No patient was admitted or had surgery. [Annals of Emergency Medicine. 56(3):270-4, 2010 Sep. PMID: 20346537]

Peanut allergy

See also Prevention, pregnancy, EAT/LEAP studies and immunotherapy.

One of the most common food allergies, and a frequent cause of anaphylaxis.  Peanut is technically a legume, although there is cross-reactivity with tree nuts so often included when people talk about “nuts”.  Always consider if there are potentially other allergies to lentils, sesame, tree nuts eg cashew etc.

Also known as groundnut or monkey nut.

[Gary Stiefel, Leicester Royal, BSACI guideline peanut allergy]

Diagnosis

Wide range of potential peanut proteins.  In US study, vast majority were Ara h1/2 positive, but European more diverse. h1, h2, h3 most common for systemic reactions.  You would think testing with whole peanut would be more sensitive but component testing probably more sensitive and specific than total IgE – but not better than skin prick testing.

peanut allergy diagnosis BSACI 2017With a decent history, SPT >3mm or IgE >0.35 sufficient.

Before proceeding to a hospital challenge, footnote suggests either 2 negatives, or else both IgE and SPT negative.

Distinguish Pollen Food Syndrome – ie older, rhinitis, oral allergy symptoms with nuts/fruit. These kids will have a milder allergy.  Hazelnut mostly (Cor a1) but almond, walnut too. But can coexist with more severe allergy! Doing grass/birch pollen would support diagnosis, doing components might help assess prognosis. If history unclear, but positive IgE/Skin prick test then do components h2 and h8 (list of different cut offs for different commercial products given, with related specificity/sensitivity, just says positive/negative in flow chart). Footnote suggests adding Ara h 1, 3 and 9 as also suggest primary peanut allergy even if Ara h 2 neg.

Sibling risk 5-9%. Too low to justify routinely screening.  If family likely to just avoid forever, living in fear, then consider SPT to encourage home challenge!?

Prognosis

Up to 20% will outgrow, usually before age 8. Review may not be necessary if PFS only.  Follow up is essentially about education.  Testing can be done periodically, depending on resources.

In a study of adults coming to allergy clinics, 10% of peanut allergic turned out not to be.  Partly this would have been because the diagnosis was wrong (many had never actually reacted to peanut in the past).  Having eczema meant you were more likely to still be positive on testing.  Having asthma and being male made it half as likely you would not be allergic anymore.  But many of the cases described were not formally challenged so these results are of limited value.  [Poster at AAI 2021, Rima Rachid]

Avoidance

Difficult, as often used in biscuits, chocolate, ethnic foods eg satay.

As for any food allergy:

Peanut needs to be specified on food labels under UK/EU law.

Precautionary labels – impossible to eliminate risk. Often these “may contain” warnings and similar just say “nuts” without specifying whether the risk is from peanut or a tree nut (the company may be able to give further information if you enquire directly). 

Snack foods with precautionary labels are higher risk eg biscuits, cakes [Helen Brough].

Balance between convenience and risk (probably a very small risk, as many families ignore these warnings to some degree).  Stratify risk according to type of food, previous reactions, threshold, asthma, illness, time of day, location etc. Crossing the road metaphor – choose a safe place!

Should you avoid all nuts?  Some kids will be allergic to other (tree) nuts, but not all.  Andrew Clark reports v low rate of accidental reactions, 3%, with avoidance of all nuts. But increases quality of life to be allowed other nuts!  Risk assessment for each individual person!

Peanut oil

Probability of any reaction to refined peanut oil is remote (Blom et al, 2017). Little evidence that anyone has ever reacted to refined peanut oil. Code of practice is that presence of UNREFINED peanut oil should be declared on bottles of oil (UK and Europe).

But peanut oil, even if refined, still has to be declared on food labels.  Beware unrefined oil in ethnic foods.  Peanut oil also found in some medicines eg vitamins, antibiotic creams.

Some suspicion that peanut oil in cosmetics and pharmaceuticals might lead to sensitization and subsequent peanut allergy, even if not enough peanut protein to cause a reaction in an allergic person. So advice is avoid if you have a strong family history of allergy.

Immunotherapy

See Peanut immunotherapy.

X-linked lymphoproliferative syndrome (XLP)

(also known as , Duncan’s syndrome)

An immunodeficiency due (in 50% of cases) to SLAM associated protein (SAP) defect, specifically affecting the handling of EBV, affected boys are normal until they meet the virus. Following infection, they develop profound secondary immune deficiency affecting T and NK cell function and antibody responses. The following clinical patterns (not mutually exclusive) are described (and can be presenting features):

  • severe infectious mononucleosis
  • malignant B cell lymphoma (ie monoclonal proliferation)
  • Lymphoproliferation viz hepatosplenomegaly (ie polyclonal proliferation)
  • aplastic anemia
  • panhypogammaglobulinemia
  • haemophagocytic lymphohistiocytosis (HLH)
  • vasculitis

The prognosis is very poor with 75-85% mortality. Confirmation of the diagnosis involves demonstrating EB virus genome in lymphocytes by DNA hybridization, without antibody response to EB nuclear antigen (EBNA). The mothers of affected boys also have abnormal EB virus serology, with persisting very high titers against viral capsid antigen. Treatment is with Rituximab (anti CD20), although EBV receptor is CD21. If diagnosed in a sibling before they are infected by the virus, regular IVIG as passive immunization can be attempted though its efficacy is unproven.

Autosomal forms have been described.

OMIM entry

 

Severe Combined Immunodeficiency (SCID)

Mixed bag of diseases, with combined T and B cell deficits. “Severe” tends to mean severe lymphopenia and panhypogammaglobulinaemia with poor prognosis. Usually a bone marrow problem, with defective maturation of precursors – so depending on where the block is there may or may not be T cells, B cells, NK cells. A problem further down the line at the signalling stage will tend to mean immunoglobulin is produced, but not functional, esp since T cell regulation is needed too. So the clinical picture may be of a combined defect even if B cells and immunoglobulin are present. On the other hand, some defects are “leaky”, ie some precursors do manage to develop past the block by having reversion mutations causing somatic mosaicism. The other possible source of T cells if present is that they may be maternal (do FACS CD3 vs TCR to discriminate). To test, find appropriate T cell markers. Such T cells usually not functional but may ameliorate severity or prevent progression.

Typical presentation

Affected babies appear well at birth and are normally grown. Problems usually start within the first few months of life. Common presentations are:

  • Chronic diarrhoea and failure to thrive – often due to persistent and sometimes multiple gastrointestinal infection, +/-food intolerance.
  • Candidiasis
  • Severe bacterial infections esp pneumonia unresponsive to standard treatment
  • Atypical infections eg Pneumocystis jiroveci/carinii, disseminated BCG infection. PCP can be acute or chronic, causes interstitial pneumonia with disproportional hypoxia for degree of illness, LDH is often raised (non-specific, implies tissue invasion).
  • Reticular skin rash +/-mildly deranged LFTs – Graft-versus-host disease (GVHD) – since you can’t reject foreign tissues, you may show GVHD if maternal lymphocytes cross the placenta (usually mild) or via breast-feeding (very mild, not a contraindication). Role in gastrointestinal symptoms? More severe GVHD can follow blood transfusion – hence all lymphopenic patients should get irradiated blood to kill donor white cells. Differential is disseminated CMV, CD40 ligand deficiency, Omenns, ICF. Diagnosis is by finding 2 cell populations by chimerisms.
  • Occasionally SCID can present like Langerhans cell histiocytosis with dramatic erythrodermic or scaly rash, organomegaly (Omenns).

On examination (usually), no lymph nodes; no thymic shadow on chest X-ray (development of thymus requires appropriate signals from bone marrow). Hepatomegaly (?). Investigations usually reveal lymphopenia (<2.8 in first year), and there may or may not be NK cells – the exact pattern helps you work out where the block is. Odd results may reflect presence of maternal lymphocytes! Mitogen responses (proliferation studies) are usually absent. IgG will usually be present from Mum, but gets used up quickly! IgA and IgM may be present if B cells are present, but usually limited clonal diversity so not much function and no specific antibody responses.

Subtypes

B- NK- is ADA. B+ NK+ is IL7R defect. B+ NK- is gamma chain or JAK3 (the two bind to each other). B- NK+ is RAG or Artemis. Bare lymphocytes (T but not CD4) are HLA deficient.

Complex, because the defect can relate to cytokine signalling, T-cell receptor signalling, receptor gene recombination etc.

The biggest group are T- B+ NK-: the main cause is Gamma chain deficiency, which is X-linked. About 50% of all SCID. The Gamma chain is found in numerous cytokines (IL-2, 4, 7, 9 and 15), hence why it causes severe problems. JAK3 binds to gamma chain so causes an identical syndrome.

The next main group are T- B- NK-: Adenosine deaminase (ADA) deficiency is the main cause. Accumulation of toxic deoxyadenosine triphosphate (d-ATP) in lymphocytes leads to cell death. All cell lines are reduced. Additional features are:

  • Skeletal abnormalities (cupping deformities of the ends of the ribs, abnormalities of the transverse vertebral processes and the scapulae) are seen in up to 50% of cases and can be correlated with histological changes.
  • Neurodevelopmental problems may also occur in some patients.

Occasional cases of ADA deficiency have been described, where inexplicably, immune function is normal. The diagnosis is confirmed by assay of red cell ADA activity (Purine lab, Guy’s). First trimester antenatal diagnosis is possible. Gene therapy is done in London and Paris.

Purine nucleoside phosphorylase (PNP) deficiency is initially less severe than ADA deficiency but progresses with age. It is autosomal recessive (gene is on chromosome 9). The toxic metabolite is deoxyguanosine triphosphate. Immunoglobulin levels and antibody responses are initially normal but in the late stages levels fall.

PNP vs ADA

  • Onset of symptoms is usually later, can be delayed for several years.
  • Predominantly cell-mediated defect (viruses, fungi, GVHD).
  • Marked tendency to autoimmune disease, esp hemolytic anemia (even red cell aplasia).
  • No skeletal abnormalities, but more neurodevelopmental probs.
  • Partial, asymptomatic, forms of the deficiency have not been reported.

Reticular dysgenesis (autosomal recessive) is characterized by an absence of myeloid as well as lymphoid precursors, so no neutrophils or macrophages. Platelets and red cells are usually OK but can be low too! Even more severe than other forms of SCID, tends to present very early. Often GVHD rash. Hard to transplant…

The T- B- NK+ group are to do with VDJ recombination. The main one here is RAGs (recombination activating genes, 1 and 2) defect. If you can’t recombine these variable areas, then you can’t develop the necessary diversity in antigen receptors on T and B cells. Artemis and Ligase 4 similarly. NK don’t use them so they’re fine. Diagnose by looking at Ig gene rearrangements.

Ommen’s syndrome is a leaky B- SCID, usually a RAG defect, but characterised by:

  • infiltrative skin rash resembling seborrheic dermatitis (scaling, erythroderma): histologically, proliferation of CD8/CD4 double negative cells and histiocytes.
  • hepatomegaly and lymphadenopathy
  • lymphocytosis but with marked eosinophilia and raised IgE levels

Diagnosis is confirmed by showing limited TCR Vbeta clonal populations (the few clones leaking past the block expand in the periphery to cause the signs). Differential is GVHD (usually milder, not lymph nodes usually), congenital ichthyosis and Nethertons syndrome (autosomal recessive ichthyosis with immunodeficiency and growth failure). Interferon gamma may produce some clinical improvement but definitive treatment is with bone marrow transplantation.

The final group, T- B+ NK+, is a mixed bag of different problems, all to do with signal transduction:

  • ZAP-70 defect (CD8 deficiency, AR) – defective kinase, part of the CD3/TCR complex. Whereas CD8s are absent, CD4 and other cells are present.
  • JAK-3 defect – Janus kinase 3, a tyrosine kinase, interacts with the STAT (signal transduction and activators of transcription) family (AR).
  • IL7R defect

Defects in cytokine production are not really SCID:

  • IL-1, IL-2 and interferon gamma deficiency described, result in a spectrum of clinical problems including failure to thrive and opportunistic infections. Humoral immunity is relatively preserved.
  • Interferon gamma receptor defects predispose to disseminated atypical mycobacterial infection (see above).
  • IRAK (IL1R Associated Kinase) defect – like NEMO, broad range of cytokines affected. Typical infections are Pseudomonas, pneumococci, salmonella. NOT candida, viruses, mycobacteria, fungi. 50% die within first 3 years, thereafter survival improves markedly.The following have normal cell populations but abnormal surface molecules:
    • Bare lymphocyte syndrome (AR). You have T cells, but they don’t differentiate into CD4 and CD8 cells. Usually due to defective HLA expression. T and B cell numbers are normal! CD4 count is low in Class II and the CD8 count in Class I deficiency. Confirmation of the diagnosis depends on demonstration of the absence of the HLA antigens on the cells. Other weird features:
      • lymph nodes are palpable and the thymus is normal size (not histologically normal, mind you).
      • Mitogen responses are normal but antigen specific responses and delayed hypersensitivity tests are negative.
    • CD3 deficiency – also gives normal numbers of circulating T and B cells, so thymus and lymph nodes present. CD3 actually made up of several different chains, so In delta chain defect, the T cells make it to the thymus but don’t progress into the circulation.
    • Fas (CD95) deficiency = Autoimmune Lymphoproliferative Syndrome (30% have unknown mutations). This is a cell surface molecule important in apoptosis, hence lymphoproliferation ie massive lymphadenopathy, hepatosplenomegaly (but variable). It is expressed on thymocytes and activated T cells. Most obvious manifestation of autoimmunity is cytopenias. CD4 cells are low but lymphocyte count is normal by virtue of a proliferation of CD4/CD8 double negative cells (eg 30-60% of total). LNs have characteristic histology. Rx immunosuppression, usually pred and high dose IVIG are sufficient although may need extended treatment. MMF and rituximab have been used.
    • OKT4 deficiency is a defect in an epitope on the CD4 molecule recognized by a monoclonal antibody of that name. There is a mild immunodeficiency and a tendency to autoimmune disease.
    • Idiopathic CD4 lymphocytopenia. Usually adults, but can be seen in children. Affected individuals are highly susceptible to opportunistic infections, obviously; immunoglobulin levels and antibody responses are generally normal. The CD4 cell count seems to remain stable for a prolonged period cf HIV infection. Prophylaxis against Pneumocystis carinii infection should be given.

    Management of SCID

    Flow cubicle, sterile handling, Septrin, Itraconazole, IVIG prophylaxis. If unable to get flow, discharge from general paeds ward!

    PEG-ADA available for ADA deficiency. Use d-ATP levels to guide dosing. Treat while looking for transplant match.

    BMT or PBSC if match available. Haploidentical (ie parent) BMT have poor results in Europe but currently 80% success rates in UK (cf 97% success for full HLA match). No big breakthrough in BMT science, just incremental improvements in conditioning regimens, supportive care, graft manipulation. Non SCID success rate is currently 69%; the rate is actually falling as more risky cases are now taken on. MUD for Wiskot Aldrich has 85% 10yr survival rate; a good MUD, using genomic rather than serological matching, is probably just as good as a sibling transplant. Other issues:

    • Cord transplants: new cord bank in Newcastle. Better engraftment cf regular BMT but you still need a good match to avoid GVHD. Above 15kg, 1 cord is unlikely to yield enough cells – use 2?
    • If CMV infected, then using a CMV pos donor may be a good thing!
    • Busulphan usually makes you infertile.
    • Fludarabine/melphalan and Campath looks like a good conditioning regimen but historical controls of limited meaningfulness in BMT work. With lower intensity regimens, poor engraftment can always be boosted with more stem cells…
    • 20 CGDs done in Newcastle – 1 death after conditioning, 1 chronic GVHD else all successful!
    • Note strong age effect – older kids do worse. Psychological? More established organ damage?
    • Some “unnecessary” transplants may need to be done, to avoid missing an opportunity to cure 1 case that might go on to do badly in later life.
    • GVHD is rarely a long term problem in kids. Long term complications are infertility, hypothyroidism, prior organ damage.

    Gene therapy: T cell count starts to rise from 12 weeks onwards. GVHD may present at that point, but resolves spontaneously. 8 patients done so far in UK, only 1 non-responder who was an adult (not surprising, too old for thymic reconstitution), 2 have stopped IVIG treatment. More done in Paris, but 2 cases of malignancy; risk associated with number of cells returned. New gene therapy trials for CGD and ADA-type SCID.

Chediak-Higashi syndrome

A neutrophil disorder.

Issue is lysosomes, so large vesicles seen in neutrophils which have reduced function. Associated with albinism, developmental delay, bleeding disorder. The connection is that all have granules, and the defect is in way that endoplasmic reticulum sorts different products into different granules.

Griscelli syndrome is similar, associated with albinism but not developmental delay or bleeding. Can predispose to haemophagocytic syndrome. Differentiate from Chediak Higashi by light microscopy of hair (unevenly distributed large melanin granules cf evenly distributed; white under polarized light cf polychromatic).

Hermansky Pudlak II has the albinism, developmental delay and bleeding, but has pigmented macrophages instead of funny neutrophils. The neutrophil numbers as well as function are reduced, whereas other subtypes do not have any immunodeficiency. Check bleeding time.

Leucocyte adhesion disorders

3 types, 1= beta2 integrin defect (no adhesion), 2=selectin ligand (a fucose transporter; no rolling), 3= RAP1. Classically delayed cord separation (but actually seen in any neutrophil disorder), skin ulcers esp perianal, periodontitis, raised white cell count (because they are stimulated but don’t move about normally). Developmental delay and hepatosplenomegaly is seen in type 2, bleeding disorder seen in type 3.

Chemotaxis disorders tend to produce pretty mild disease eg periodontitis only…

Central serous chorioretinopathy

Central serous chorioretinopathy (CSCR) = accumulation of subretinal fluid at the posterior pole of the fundus, ultimately leading to retinal detachment. Typically affects one eye only.  Vision becomes blurry and distorted, with objects often appearing smaller in the affected eye. May also cause difficulty with bright lights and contrast sensitivity.

Mechanism unknown, but associated with use of systemic corticosteroids, pregnancy, and Cushing’s syndrome.  Recently also been described after local corticosteroids including inhaled, intranasal, topical and periocular (!). Rare though.

Although blurred vision is a symptom of CSCR, it can be a side effect of periocular steroid treatment, as well as a symptom of whatever underlying eye condition is present (if any).

MHRA therefore says you should inform patients they should report any vision problems or disturbances.

[MHRA]